Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion
Recruiting
Phase 4
Interventional Study
Spinal Fusion
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- Up to 26
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Akron Children's Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Bacterial in the subdermal layer of the skin, such as in hair follicles and sweat glands, may contaminate surgical wounds. The goal of this study is to learn about povidone-iodine and its ability to prevent infections specifically in patients with scoliosis receiving a spinal fusion.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
* Males and females
* Undergoing primary posterior spinal fusion of the thoracic and/or lumbar spine
* English Speaking
Exclusion Criteria
* Patients who have undergone prior spinal surgery
* Undergoing procedures other than primary posterior spinal fusion of the thoracic and/o…
Contacts